Design of β-amyloid aggregation inhibitors from a predicted structural motif.
about
Virtual and In Vitro Screens Reveal a Potential Pharmacophore that Avoids the Fibrillization of Aβ1-42Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies.Nanomaterials enhanced surface plasmon resonance for biological and chemical sensing applications.New multi-target-directed small molecules against Alzheimer's disease: a combination of resveratrol and clioquinol.Kisspeptin prevention of amyloid-β peptide neurotoxicity in vitro.Synthesis of tetrahydroxybiphenyls and tetrahydroxyterphenyls and their evaluation as amyloid-β aggregation inhibitors.The role of molecular simulations in the development of inhibitors of amyloid β-peptide aggregation for the treatment of Alzheimer's diseaseComputational and experimental studies on β-sheet breakers targeting Aβ1-40 fibrils.New cylindrical peptide assemblies defined by extended parallel β-sheets.Computer-assisted designed "selenoxy-chinolin": a new catalytic mechanism of the GPx-like cycle and inhibition of metal-free and metal-associated Aβ aggregation.Scrutiny of the mechanism of small molecule inhibitor preventing conformational transition of amyloid-β42 monomer: insights from molecular dynamics simulations.A dimer model of human calcitonin13-32 forms an α-helical structure and robustly aggregates in 50% aqueous 2,2,2-trifluoroethanol solution.
P2860
Q28546473-2A8FB1AD-E103-4D1C-B826-C84066104990Q33893017-12DE6112-B188-46C3-B4C3-14CD2BC9F49CQ34405112-B6ABE264-D301-429D-A9B8-01FD76CDB458Q35199867-D7B958FC-8FB0-4BD6-BB97-A1B7108135D6Q36248549-546DA5FC-3CCC-43C4-9161-4B239ADBB76CQ36675390-CFE7D8FA-A146-4E93-8ADD-973ADAA0196EQ38061633-76500C40-5414-4DC5-A0CF-12111C2C4D09Q39997860-42FB6546-2F50-479B-9B9D-7B533D90DFB1Q45899619-4F1788AB-BD20-4351-A63C-7CF95D05FC68Q46638758-80F50C05-5CC5-4F35-88BA-E04C52BE56EAQ48323909-833E4B23-317C-4F56-AF8B-3651FF26DDA1Q54011312-49973E09-4560-4ECB-AE0A-F55509E73B9D
P2860
Design of β-amyloid aggregation inhibitors from a predicted structural motif.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Design of β-amyloid aggregation inhibitors from a predicted structural motif.
@ast
Design of β-amyloid aggregation inhibitors from a predicted structural motif.
@en
Design of β-amyloid aggregation inhibitors from a predicted structural motif.
@nl
type
label
Design of β-amyloid aggregation inhibitors from a predicted structural motif.
@ast
Design of β-amyloid aggregation inhibitors from a predicted structural motif.
@en
Design of β-amyloid aggregation inhibitors from a predicted structural motif.
@nl
prefLabel
Design of β-amyloid aggregation inhibitors from a predicted structural motif.
@ast
Design of β-amyloid aggregation inhibitors from a predicted structural motif.
@en
Design of β-amyloid aggregation inhibitors from a predicted structural motif.
@nl
P2093
P2860
P356
P1476
Design of β-amyloid aggregation inhibitors from a predicted structural motif.
@en
P2093
Alexandra Esteras-Chopo
Dahabada H Lopes
Isabella A Graef
Kim M Branson
Paul A Novick
Vijay S Pande
P2860
P304
P356
10.1021/JM201332P
P407
P577
2012-03-15T00:00:00Z